Comvita Limited — Director's Dealing 2021

Sep 27, 2021

DocuSign Envelope ID: B8C42E42-A87D-4E58-BE83-C8D32932B772

==> picture [81 x 22] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Comvita Limited Date this disclosure made: 28-Sep-21 Date of last disclosure: 1-Sep-21 Director or senior manager giving disclosure Full name(s): David Robert Banfield Name of listed issuer: Comvita Limited Name of related body corporate (if applicable): N/A Position held in listed issuer: CEO and Managing Director Summary of acquisition or disposal of relevant interest (excluding specified derivatives) Ordinary shares Class of affected quoted financial products: Performance share rights Nature of the affected relevant interest(s): Registered Holder For that relevant interest- 521,561 ordinary shares (184,073 held by David Banfield and 337,488 held on behalf of the David Number held in class before acquisition or disposal: and Joy Banfield Trust 106,213 performance share rights 533,392 ordinary shares (195,904 held by David Banfield and 337,488 held on behalf of the David Number held in class after acquisition or disposal: and Joy Banfield Trust 94,382 performance share rights Current registered holder(s): David Banfield, Joy Banfield and Julian Donald as trustees for the David and Joy Banfield Trust Registered holder(s) once transfers are registered: David Banfield Details of transactions giving rise to acquisition or disposal Total number of transactions to which notice relates: 1 Details of transactions requiring disclosure- Date of transaction: 28-Sep-21 11,831 shares issued under the Comvita Limited Nature of transaction: Performance Share Rights Scheme Name of any other party or parties to the transaction (if known): Comvita Limited The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Nil Number of financial products to which the transaction related: 11,831 ordinary shares If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: No Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any): Summary of other relevant interests after acquisition or disposal: Class of quoted financial products: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): Certification I, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:

28-Sep-21